{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T04:20:26Z","timestamp":1771302026695,"version":"3.50.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T00:00:00Z","timestamp":1671494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T00:00:00Z","timestamp":1671494400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>The aim of this study was to identify early clinical features of patients with new-onset refractory status epilepticus (NORSE) that could direct the treatment in the first days of hospitalisation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A retrospective cohort study of adult NORSE patients treated in the intensive care units of Helsinki University Hospital 2007-2018.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We found 19 adult NORSE patients who divided into three subgroups on the basis of their clinical features: viral encephalitis (<jats:italic>n<\/jats:italic>\u2009=\u20095, 26%), febrile infection-related epilepsy syndrome (FIRES) (<jats:italic>n<\/jats:italic>\u2009=\u20096, 32%) and afebrile NORSE (<jats:italic>n<\/jats:italic>\u2009=\u20098, 42%). FIRES and afebrile NORSE patients remained without confirmed etiology, but retrospectively two paraneoplastic and two neurodegenerative causes were suspected in the afebrile NORSE group.<\/jats:p><jats:p>Viral encephalitis patients were median 64\u2009years old (IQR 55-64), and four (80%) had prodromal fever and abnormal findings in the first brain imaging. FIRES patients were median 21\u2009years old (IQR 19-24), all febrile and had normal brain imaging at onset. In the afebrile NORSE group, median age was 67 (IQR 59-71) and 50% had prodromal cognitive or psychiatric symptoms. FIRES patients differed from other NORSE patients by younger age (<jats:italic>p<\/jats:italic>\u2009=\u20090.001), respiratory prodromal symptoms (<jats:italic>p<\/jats:italic>\u2009=\u20090.004), normal brain MRI (<jats:italic>p<\/jats:italic>\u2009=\u20090.044) and lack of comorbidities (<jats:italic>p<\/jats:italic>\u2009=\u20090.011). They needed more antiseizure medications (<jats:italic>p<\/jats:italic>\u2009=\u20090.001) and anesthetics (<jats:italic>p<\/jats:italic>\u2009=\u20090.002), had a longer hospital stay (<jats:italic>p<\/jats:italic>\u2009=\u20090.017) and more complications (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Among febrile NORSE patients, FIRES group was distinctive due to patients\u2019 young age, prodromal respiratory symptoms and normal first brain imaging. These features should be confirmed by subsequent studies as basis for selecting patients for early intensive immunotherapy.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12883-022-03028-y","type":"journal-article","created":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T06:02:51Z","timestamp":1671516171000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Early clinical features of new-onset refractory status epilepticus (NORSE) in adults"],"prefix":"10.1186","volume":"22","author":[{"given":"Anna","family":"Haanp\u00e4\u00e4","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sini M.","family":"Laakso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antti","family":"Kinnunen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leena","family":"K\u00e4mppi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nina","family":"Forss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,12,20]]},"reference":[{"issue":"4","key":"3028_CR1","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1111\/epi.14016","volume":"59","author":"LJ Hirsch","year":"2018","unstructured":"Hirsch LJ, Gaspard N, van Baalen A, Nabbout R, Demeret S, Loddenkemper T, et al. Proposed consensus definitions for new-onset refractory status epilepticus (NORSE), febrile infection-related epilepsy syndrome (FIRES), and related conditions. Epilepsia. 2018;59(4):739\u201344.","journal-title":"Epilepsia."},{"issue":"4","key":"3028_CR2","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1093\/brain\/84.4.680","volume":"84","author":"G Lyon","year":"1961","unstructured":"Lyon G, Dodge P, Adams R. The acute encephalopathies of obscure origin in infants and children. Brain. 1961;84(4):680\u2013708.","journal-title":"Brain."},{"key":"3028_CR3","volume-title":"New-onset refractory status epilepticus Etiology, clinical features, and outcome","author":"N Gaspard","year":"2015","unstructured":"Gaspard N, Foreman BP, Alvarez V, Kang CC, Probasco JC, Jongeling AC, et al. New-onset refractory status epilepticus Etiology, clinical features, and outcome. 2015."},{"key":"3028_CR4","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1111\/epi.14022","volume":"59","author":"N Gaspard","year":"2018","unstructured":"Gaspard N, Hirsch LJ, Sculier C, Loddenkemper T, van Baalen A, Lancrenon J, et al. New-onset refractory status epilepticus (NORSE) and febrile infection\u2013related epilepsy syndrome (FIRES): State of the art and perspectives. Epilepsia. Blackwell Publishing Inc. 2018;59:745\u201352.","journal-title":"Epilepsia"},{"issue":"12","key":"3028_CR5","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1002\/acn3.51229","volume":"7","author":"YC Lai","year":"2020","unstructured":"Lai YC, Muscal E, Wells E, Shukla N, Eschbach K, Lee KH, et al. Anakinra usage in febrile infection related epilepsy syndrome: an international cohort. Ann Clin Transl Neurol. 2020;7(12):2467\u201374.","journal-title":"Ann Clin Transl Neurol"},{"issue":"6","key":"3028_CR6","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1002\/ana.25374","volume":"84","author":"JS Jun","year":"2018","unstructured":"Jun JS, Lee ST, Kim R, Chu K, Lee SK. Tocilizumab treatment for new onset refractory status epilepticus. Ann Neurol. 2018;84(6):940\u20135.","journal-title":"Ann Neurol"},{"key":"3028_CR7","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.seizure.2017.12.007","volume":"55","author":"L K\u00e4mppi","year":"2018","unstructured":"K\u00e4mppi L, Mustonen H, Kotisaari K, Soinila S. The essence of the first 2.5\u00a0h in the treatment of generalized convulsive status epilepticus. Seizure. 2018;55:9\u201316.","journal-title":"Seizure"},{"key":"3028_CR8","unstructured":"StatFin. Population according to age (1-year) and sex by area, 1972-2020. p. https:\/\/pxnet2.stat.fi\/PXWeb\/pxweb\/en\/StatFin\/Stat."},{"issue":"1","key":"3028_CR9","doi-asserted-by":"publisher","first-page":"48","DOI":"10.5698\/1535-7597-16.1.48","volume":"16","author":"T Glauser","year":"2016","unstructured":"Glauser T, Shinnar S, Gloss D, Alldredge B, Arya R, Bainbridge J, et al. Evidence-based guideline: treatment of convulsive status epilepticus in children and adults: report of the guideline committee of the American epilepsy society. Epilepsy Curr. 2016;16(1):48\u201361.","journal-title":"Epilepsy Curr"},{"issue":"16","key":"3028_CR10","doi-asserted-by":"publisher","first-page":"e2280","DOI":"10.1212\/WNL.0000000000010787","volume":"95","author":"E Matthews","year":"2020","unstructured":"Matthews E, Alkhachroum A, Massad N, Letchinger R, Doyle K, Claassen J, et al. New-onset super-refractory status epilepticus: a case series of 26 patients. Neurology. 2020;95(16):e2280\u20135.","journal-title":"Neurology."},{"key":"3028_CR11","doi-asserted-by":"publisher","first-page":"108387","DOI":"10.1016\/j.yebeh.2021.108387","volume":"125","author":"A Neligan","year":"2021","unstructured":"Neligan A, Kerin B, Walker MC, Rajakulendran S. New-onset refractory status epilepticus (NORSE): the Queen square neuro-ICU experience. Epilepsy Behav. 2021;125:108387.","journal-title":"Epilepsy Behav"},{"issue":"4","key":"3028_CR12","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1111\/ene.14624","volume":"28","author":"A Gonzalez-Martinez","year":"2021","unstructured":"Gonzalez-Martinez A, Quintas S, Redondo N, Casado-Fern\u00e1ndez L, Vivancos J. Sporadic Creutzfeldt\u2013Jakob disease with tau pathology mimicking new-onset refractory non-convulsive status epilepticus: case report and review of the literature. Eur J Neurol. 2021;28(4):1385\u201391.","journal-title":"Eur J Neurol"},{"key":"3028_CR13","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.seizure.2018.09.018","volume":"68","author":"C Sculier","year":"2019","unstructured":"Sculier C, Gaspard N. New onset refractory status epilepticus (NORSE). Seizure. W.B. Saunders Ltd. 2019;68:72\u20138.","journal-title":"Seizure"},{"key":"3028_CR14","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.seizure.2019.12.002","volume":"74","author":"JJ Gugger","year":"2020","unstructured":"Gugger JJ, Husari K, Probasco JC, Cervenka MC. New-onset refractory status epilepticus: a retrospective cohort study. Seizure. 2020;74:41\u20138.","journal-title":"Seizure."},{"key":"3028_CR15","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1111\/epi.14684","volume":"60","author":"S Culleton","year":"2019","unstructured":"Culleton S, Talenti G, Kaliakatsos M, Pujar S, D\u2019Arco F. The spectrum of neuroimaging findings in febrile infection-related epilepsy syndrome (FIRES): A literature review. Epilepsia. Blackwell Publishing Inc. 2019;60:585\u201392.","journal-title":"Epilepsia"},{"issue":"11","key":"3028_CR16","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1111\/j.1528-1167.2011.03250.x","volume":"52","author":"U Kramer","year":"2011","unstructured":"Kramer U, Chi CS, Lin KL, Specchio N, Sahin M, Olson H, et al. Febrile infection-related epilepsy syndrome (FIRES): pathogenesis, treatment, and outcome: a multicenter study on 77 children. Epilepsia. 2011;52(11):1956\u201365.","journal-title":"Epilepsia."},{"issue":"7","key":"3028_CR17","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1111\/j.1528-1167.2010.02535.x","volume":"51","author":"A Van Baalen","year":"2010","unstructured":"Van Baalen A, H\u00e4usler M, Boor R, Rohr A, Sperner J, Kurlemann G, et al. Febrile infection-related epilepsy syndrome (FIRES): a nonencephalitic encephalopathy in childhood. Epilepsia. 2010;51(7):1323\u20138.","journal-title":"Epilepsia."},{"issue":"5","key":"3028_CR18","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.braindev.2007.10.008","volume":"30","author":"CS Shyu","year":"2008","unstructured":"Shyu CS, Lee HF, Chi CS, Chen CH. Acute encephalitis with refractory, repetitive partial seizures. Brain and Development. 2008;30(5):356\u201361.","journal-title":"Brain and Development"},{"issue":"7","key":"3028_CR19","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.seizure.2013.04.005","volume":"22","author":"RH Caraballo","year":"2013","unstructured":"Caraballo RH, Reyes G, Avaria MFL, Buompadre MC, Gonzalez M, Fortini S, et al. Febrile infection-related epilepsy syndrome: a study of 12 patients. Seizure. 2013;22(7):553\u20139.","journal-title":"Seizure."},{"issue":"4","key":"3028_CR20","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1055\/s-0032-1323848","volume":"43","author":"A Van Baalen","year":"2012","unstructured":"Van Baalen A, H\u00e4usler M, Plecko-Startinig B, Strautmanis J, Vlaho S, Gebhardt B, et al. Febrile infection-related epilepsy syndrome without detectable autoantibodies and response to immunotherapy: a case series and discussion of epileptogenesis in FIRES. Neuropediatrics. 2012;43(4):209\u201316.","journal-title":"Neuropediatrics."},{"issue":"3","key":"3028_CR21","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/ana.25416","volume":"85","author":"C Kellinghaus","year":"2019","unstructured":"Kellinghaus C, Rossetti AO, Trinka E, Lang N, May TW, Unterberger I, et al. Factors predicting cessation of status epilepticus in clinical practice: data from a prospective observational registry (SENSE). Ann Neurol. 2019;85(3):421\u201332.","journal-title":"Ann Neurol"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-022-03028-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-022-03028-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-022-03028-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,3]],"date-time":"2023-12-03T08:32:39Z","timestamp":1701592359000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-022-03028-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,20]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["3028"],"URL":"https:\/\/doi.org\/10.1186\/s12883-022-03028-y","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,20]]},"assertion":[{"value":"16 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All methods were carried out in accordance with relevant guidelines and regulations. Informed consent and ethical approval waiver was received from the institutional review board of Helsinki University Hospital. This manuscript adheres to the applicable Strengthening the Reporting of Observational studies in Epidemiology (STROBE) statement.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics aproval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"495"}}